Furthermore, overexpression of the BMP2 ligand has been documented in a variety of carcinoma-derived cell lines [45] and identified as being dysregulated in primary pancreatic cancer, oral squamous cell carcinoma and non-small-cell lung cancers [46,47,48,49]. This evidence concerns the gene BMP2 and non-small cell lung carcinoma.